Imidazoline-2 receptor (I₂ receptor (I2 receptor))

Imidazoline-2 receptor is a class of orphan receptor sites originally defined by their high-affinity binding to idazoxan and other imidazoline ligands. Unlike classic G protein-coupled receptors, the molecular identity of the I₂ receptor is heterogeneous and not completely defined, with some binding sites attributed to brain creatine kinase and others postulated but not characterized. I₂ receptors are concentrated on the mitochondrial membrane in various tissues, prominently in the brain, heart, kidney, and skeletal muscle. Pharmacological studies have shown I₂ ligands provide robust analgesic and neuroprotective effects in animal models, and one selective I₂ ligand (CR4056) has advanced to clinical trials for chronic pain. The receptor (or collection of sites) may also play a role in body temperature regulation and potentially psychiatric and neurodegenerative disorders. Despite its therapeutic promise, the Imidazoline-2 receptor remains a challenging drug target due to its unclear molecular nature and functional heterogeneity[2][3][4][7][8][9].

Other names

I2-imidazoline receptorI2 binding siteI2-IR

Allosteric modulation of monoamine oxidase (MAO) activity Agonist-mediated analgesia and neuroprotection (not fully understood, as molecular target is heterogeneous)